Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy. [electronic resource]
Producer: 20200312Description: 2365-2377 p. digitalISSN:- 1460-2083
- Animals
- Cell Line
- Cell Movement
- Cell Proliferation
- Citalopram -- pharmacology
- Drosophila -- drug effects
- Drug Evaluation, Preclinical
- Humans
- Membrane Proteins -- genetics
- Mice
- Mice, Knockout
- Muscle, Skeletal -- metabolism
- Muscular Diseases -- drug therapy
- Mutation
- Myoblasts -- drug effects
- Receptor, Notch1 -- metabolism
- Selective Serotonin Reuptake Inhibitors -- pharmacology
- Sertraline -- pharmacology
- Signal Transduction
- Zebrafish -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.